Roundtable on Community Health and Advancing Health Equity

Download the Increasing Vaccine Uptake in Diverse Communities Guide >

This Roundtable supports partnerships between payer, provider and life sciences companies that can improve community health and advance health equity among racial groups and vulnerable populations. Special attention will be given to automating health data capture and assessment at the community level and addressing structural barriers to management of social determinants of longer-term population health. The goal of this Roundtable is to accelerate adoption of new models for improving the health of a community and promoting health equity for and among local populations. A crucial part of this work will include engaging with and listening to community members and partnering with key community organizations.

Each Forum Roundtable strikes a balance between near-term COVID-related challenges and long-term impact on major issues in the post-pandemic world through professional facilitation and deep subject matter expertise. The groups will develop and widely disseminate recommendations that will make an impact on provider, payer and life sciences CEOs, policymakers and thought leaders collaborating for industry-wide change.


  • Mandy Cohen, MD, Secretary, North Carolina Department of Health and Human Services

  • Pat Geraghty, President & CEO, GuideWell & Florida Blue

  • Rod Hochman, MD, President & CEO, Providence

  • Wright Lassiter, III, President & CEO, Henry Ford Health System; Chair-Elect of AHA

  • Mark Smith, MD, Founding President & Former CEO, California Health Care Foundation

  • Paul Tufano, Chairman & CEO, AmeriHealth Caritas

Industry Adviser

  • Tim Suther, SVP & General Manager, Data Solutions, Change Healthcare

Roundtable Partner


Roundtable Fellows

Tayo Akins, Cascade Comprehensive Care

Tosan Boyo, John Muir Health

Bruce Broussard, Humana, Inc.

Carrie Byington, University of California Health

Mandy Cohen, MD, North Carolina Department of Health and Human Services

Scott Doniger, DaVita Inc.


Matt Eyles, America's Health Insurance Plans, Inc

Ken Fasola, Magellan Health

Kathy Feeny, Florida Blue Medicare

Tina Freese Decker, Spectrum Health

Pat Geraghty, Florida Blue & GuideWell

Julie Gerberding, MD, Merck & Co.

Russ Gronewold, Bryan Health

Patrice Harris, MD, eMed; formerly of American Medical Association

Nzinga Harrison, MD, Eleanor Health

Rod Hochman, MD, Providence

Karen Ignagni, EmblemHealth

Nimesh Jhaveri, McKesson Corporation

William Johnson, MD, MODA Health

Mary Ann Jones, PhD, Westside Community Mental Health Center

Barsam Kasravi, MD, Anthem, Inc.

Kim Keck, Blue Cross Blue Shield Association

Wright Lassiter, III, Henry Ford Health System; Chair-Elect of AHA

Brian Lobley, Independence Blue Cross

Dawn Maroney, Alignment Healthcare

Trevor Martin, Mammoth Biosciences

Stephen Mette, MD, University of Arkansas for Medical Sciences Medical Center

Bruce Meyer, Jefferson Health

Steve Miff, PhD, Parkland Center for Clinical Innovation

Shawn Morris, Privia Health

Lawrence Moss, MD, Nemours Children's Health System

Kirti Mutatkar, UnitedAg

John Naylor, Medica

Felicia Norwood, Anthem, Inc.

Nwando Olayiwola, MD, Humana, Inc.

Randy Oostra, Promedica Health System

Aaron Perry, Rebalanced-Life Wellness Association

Terry Shaw, Advent Health

Puneet Singh, Quartet Health

Mark Smith, MD, California Health Care Foundation

Tunde Sotunde, MD, BlueCross BlueShield of North Carolina

Todd Suntrapak, Valley Children's Healthcare

Tim Suther, Change Healthcare

Ben Wade, Stamford Health

Martha Wofford, Blue Cross Blue Shield of Rhode Island

Laurie Zephyrin, MD, The Commonwealth Fund

Work Groups

Work Groups are chartered by Roundtables to go deep on a key issue over a three-year period, and to make recommendations to Roundtable Fellows for pronouncements or actions that should be taken by the Roundtable, the Forum or by all CEOs. Work Groups are focused on:

  • Developing specific mechanisms that advance access to high-quality, affordable health care for all people
  • Identifying best practices and developing strategies for wide dissemination so observable results can be realized within 3 years
  • Addressing issues that CEOs and boards of payer, provider and life science companies would consider top priorities
  • Driving changes where the voice of payer, provider and life science CEOs and their actions matter, where private sector leaders can make progress without regulatory change and which do not require endorsement of specific products or solutions

Chartered Work Groups

Leveraging Data to Improve Health Equity

Disparities in care exist throughout the healthcare system, but many payer, provider and life science organizations have not segmented their own health outcomes data by race and socioeconomic class so as to analyze the specific situations in which those disparities are occurring among their patients or members. Until they do so, they will not be able to understand the breadth and depth of the disparities or to develop strategies to address those disparities at the patient or population level. The goal of this Work Group is to enable payer, provider and life science CEOs to identify, track and manage the impact of race on prevention and clinical care.

Building Scalable Models and Community Partnerships to Address Social Determinants of Health

Social determinants of health—including food, housing, and transportation—have a significant impact on health outcomes, particularly for vulnerable populations. With recent Medicare Advantage payment for some social determinants, many payer, provider and life science organizations are expanding their focus on social determinants interventions. However, these organizations have struggled to identify specific, evidence-based actions they can take internally and have largely not sought to form meaningful partnerships with community organizations that can deliver results that reduce the total cost of care and improve outcomes. Furthermore, a lack of proper infrastructure and incentive structures often impedes health care organizations from taking meaningful action. The goal of this Work Group is to identify specific scalable, replicable, and efficient best practices for payer, provider and life science CEOs to implement to address social determinants of health in collaboration with community organizations in order to meaningfully drive down the total cost of care and improve health outcomes for vulnerable populations.

Thought Leadership

Increasing Vaccine Uptake in Diverse Communities: A Working Guide for Health Care CEOs. Although data around vaccine distribution in America is sorely limited and scattered, one pattern is becoming increasingly clear – those who have been affected by COVID-19 the most are getting vaccinated the least. The working guide outlines 10 emerging best practices for creating an action plan that increases confidence and accessibility to the vaccine among the diverse communities you serve. Download the guide now.

This guide has been developed with significant input from Fellows of the Roundtable on Community Health and Advancing Health Equity.

Health Equity Roadmap for Health Care CEOs: Part I
Many organizations across the U.S. health care system have struggled to develop a methodical approach to identifying, quantifying, and taking action to address disparities impacting their patients and members. The Health Equity Roadmap for Health Care CEOs was created to provide a cross-sector guide for organizations that are seeking to develop an effective and data-driven enterprise-wide strategy to advance health equity. Download the roadmap now.

Contact Us for More Information